Gemcitabine-Related Pneumonitis in Pancreas Adenocarcinoma—An Infrequent Event: Elucidation of Risk Factors and Management Implications

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2015.08.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pancreas Adenocarcinoma: Ascites, Clinical Manifestations, and Management Implications

Clinical Colorectal Cancer
OncologyGastroenterology
2016English

Risk Factors and Management of Breast Cancer-Related Lymphedema

International Journal of Medicine
2015English

A Single-Arm, Nonrandomized Phase II Trial of Neoadjuvant Gemcitabine and Oxaliplatin in Patients With Resectable Pancreas Adenocarcinoma

Annals of Surgery
Surgery
2014English

An Order of Asymmetry in Copulas, and Implications for Risk Management

Insurance: Mathematics and Economics
UncertaintyEconomicsStatisticsEconometricsProbability
2016English

Adenocarcinoma of the Pancreas

Seminars in Diagnostic Pathology
Forensic MedicinePathology
2014English

Clinical Features, Diagnostic Challenges, and Management Strategies in Checkpoint Inhibitor-Related Pneumonitis

Cancer Management and Research
Oncology
2017English

Bosutinib-Related Pneumonitis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Gemcitabine and Oxaliplatin (GEMOX) in Gemcitabine Refractory Advanced Pancreatic Adenocarcinoma: A Phase II Study

British Journal of Cancer
Cancer ResearchOncology
2006English

Infrequent Use of Isolation Precautions in Nursing Homes: Implications for an Evolving Population

Journal of the American Geriatrics Society
GerontologyGeriatrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy